Literature DB >> 17916870

Testis cancer.

Omar Khan1, Andrew Protheroe.   

Abstract

Testis cancer is an increasing problem, especially in northern European male populations. However, survival has improved dramatically over one generation. Environmental factors may have a role in the aetiology with high oestrogen concentrations implicated. Testis cancer is subdivided between seminoma and non-seminoma. At presentation, a testicular lump is the most common finding and radical inguinal orchidectomy is recommended for most. Further multidisciplinary management is determined by histological subtype and stage and involves chemotherapy, radiotherapy and surgery, with many patients only undergoing surveillance. There is increasing emphasis on reducing toxicity of treatments in long term survivors. Treatment refractory testis cancer remains a significant challenge.

Entities:  

Mesh:

Year:  2007        PMID: 17916870      PMCID: PMC2600126          DOI: 10.1136/pgmj.2007.057992

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  49 in total

Review 1.  Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma.

Authors:  R S Foster; J P Donohue
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

2.  Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours.

Authors:  E A Rapley; G P Crockford; D Teare; P Biggs; S Seal; R Barfoot; S Edwards; R Hamoudi; K Heimdal; S D Fossâ; K Tucker; J Donald; F Collins; M Friedlander; D Hogg; P Goss; A Heidenreich; W Ormiston; P A Daly; D Forman; T D Oliver; M Leahy; R Huddart; C S Cooper; J G Bodmer; D F Easton; M R Stratton; D T Bishop
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

3.  Radiotherapy for stages I and IIA/B testicular seminoma.

Authors:  M Bamberg; H Schmidberger; C Meisner; J Classen; R Souchon; S Weinknecht; J Schorcht; F Walter; R Engenhart-Cabillic; U Schulz; H Born; M Flink
Journal:  Int J Cancer       Date:  1999-12-10       Impact factor: 7.396

4.  Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council.

Authors:  R de Wit; J T Roberts; P M Wilkinson; P H de Mulder; G M Mead; S D Fosså; P Cook; L de Prijck; S Stenning; L Collette
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

5.  Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group.

Authors:  S D Fosså; A Horwich; J M Russell; J T Roberts; M H Cullen; N J Hodson; W G Jones; H Yosef; G M Duchesne; J R Owen; E J Grosch; A D Chetiyawardana; N S Reed; B Widmer; S P Stenning
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

6.  Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.

Authors:  R J Motzer; J Sheinfeld; M Mazumdar; M Bains; T Mariani; J Bacik; D Bajorin; G J Bosl
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

7.  High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer.

Authors:  S Bhatia; R Abonour; P Porcu; R Seshadri; C R Nichols; K Cornetta; L H Einhorn
Journal:  J Clin Oncol       Date:  2000-10-01       Impact factor: 44.544

8.  Fertility in Norwegian testicular cancer patients.

Authors:  S D Fosså; O Kravdal
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

9.  A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.

Authors:  G M Mead; M H Cullen; R Huddart; P Harper; G J S Rustin; P A Cook; S P Stenning; M Mason
Journal:  Br J Cancer       Date:  2005-07-25       Impact factor: 7.640

10.  Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?

Authors:  D M Berney; J Shamash; W F Hendry; A Arora; S Jordan; R T Oliver
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

View more
  9 in total

1.  Percutaneous testicular biopsy for indeterminate testicular lesions.

Authors:  N Shaida; L H Berman
Journal:  Br J Radiol       Date:  2012-06-06       Impact factor: 3.039

2.  Magnetic resonance versus computed tomography for the detection of retroperitoneal lymph node metastasis due to testicular cancer: A systematic literature review.

Authors:  Andrés Felipe Herrera Ortiz; Lorena Josefina Fernández Beaujon; Sandra Yulitza García Villamizar; Freddy Fernando Fonseca López
Journal:  Eur J Radiol Open       Date:  2021-08-17

Review 3.  Pure seminoma: a review and update.

Authors:  Noureddine Boujelbene; Adrien Cosinschi; Nadia Boujelbene; Kaouthar Khanfir; Shushila Bhagwati; Eveleyn Herrmann; Rene-Olivier Mirimanoff; Mahmut Ozsahin; Abderrahim Zouhair
Journal:  Radiat Oncol       Date:  2011-08-08       Impact factor: 3.481

4.  Unusually Located Stroke After Chemotherapy in Testicular Germ Cell Tumors.

Authors:  Braulio Alexander Martinez; Edgar Patricio Correa
Journal:  J Investig Med High Impact Case Rep       Date:  2015-06-09

Review 5.  Rare cancers: Challenges & issues.

Authors:  Raveendran K Pillai; K Jayasree
Journal:  Indian J Med Res       Date:  2017-01       Impact factor: 2.375

6.  Causes of inferior relative survival after testicular germ cell tumor diagnosed 1953-2015: A population-based prospective cohort study.

Authors:  Øivind Kvammen; Tor Åge Myklebust; Arne Solberg; Bjørn Møller; Olbjørn Harald Klepp; Sophie Dorothea Fosså; Torgrim Tandstad
Journal:  PLoS One       Date:  2019-12-18       Impact factor: 3.240

Review 7.  miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update.

Authors:  Marco De Martino; Paolo Chieffi; Francesco Esposito
Journal:  Int J Mol Sci       Date:  2021-01-30       Impact factor: 5.923

Review 8.  Adult testicular cancer: Two decades of Saudi national data.

Authors:  Mohammed Abomelha
Journal:  Urol Ann       Date:  2017 Oct-Dec

Review 9.  Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer.

Authors:  Manuel Regouc; Gazanfer Belge; Anja Lorch; Klaus-Peter Dieckmann; Martin Pichler
Journal:  Cancers (Basel)       Date:  2020-03-22       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.